amiodarone has been researched along with Ovarian Neoplasms in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belur Nagaraj, A | 1 |
Joseph, P | 1 |
Kovalenko, O | 1 |
Wang, Q | 1 |
Xu, R | 1 |
DiFeo, A | 1 |
1 other study available for amiodarone and Ovarian Neoplasms
Article | Year |
---|---|
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Female; Humans; Neoplastic Stem Cells; Ovarian Neop | 2018 |